share_log

B of A Securities Downgrades Clover Health Investments to Underperform, Announces $10 Price Target

B of A Securities Downgrades Clover Health Investments to Underperform, Announces $10 Price Target

美国银行证券将三叶草健康投资评级下调至表现不佳,宣布10美元目标价
Benzinga Real-time News ·  2021/06/10 05:47

B of A Securities analyst Kevin Fischbeck downgrades Clover Health Investments (NASDAQ:CLOV) from Neutral to Underperform and announces $10 price target.

美国银行证券分析师Kevin Fischbeck将三叶草健康投资公司(纳斯达克市场代码:CLOV)的评级从中性下调至表现不佳,并宣布10美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发